Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

Articles

The landmark decision determined that biosimilar makers can notify manufacturers before receiving FDA approval. 


Supreme Court Rules in Amgen v. Sandoz

Takeda will build a new production facility at its existing Grange Castle site in Ireland.

Takeda Constructs High-Containment Facility in Ireland

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

As cost pressures mount as a result of multiple biologics being developed for the same indication, manufacturers can harness process efficiencies to maintain the value of legacy products.


Boosting Bioproduction Workflows with Automation Technologies

Tino Otte is senior consultant at Intertek, tino.otte@intertek.com, Tel: +41 (61) 686 48 56.

Follow guidelines for E&L studies of an orally inhaled and nasal drug product formulation in its delivery device.


Extractables and Leachables Testing for Inhaled Medicines

BioVectra will open its new microbial fermentation and complex chemistry site, including the capability to handle high-potency APIs, by the end of 2017.


BioVectra Builds Fermentation and Complex Chemistry Facility in Nova Scotia

Ajay Pazhayattil*, M.Pharm, DBA, Ajay.Pazhayattil@capcium.com, is vice-president, Scientific and Regulatory Affairs at Capcium.

Jana Spes is Vice-President, Technical Operations, Apotex, jspes@apotex.com.

Rakesh Singh Chaudhary is scientistâtechnical operations TSS at Apotex Inc. 

The pharmaceutical industry is making efforts by internally assessing, developing, and implementing semi-continuous manufacturing processes to improve manufacturing efficiencies. 

Continuous Manufacturing: A Generic Industry Perspective

The company will expand its production facilities in Carlow and Cork to meet increased global demand for its medicines and vaccines produced in Ireland. 

MSD Announces EUR280 Million Investment in Ireland and 330 New Jobs

CBER is moving forward with the development and approval of regenerative medicine advanced therapies.

FDA Looks to Advance Regenerative Medicine

Ablynx will receive EUR15 million in milestone payment following Merck’s decision to advance ALX-1141 into clinical development. The nanobody was developed by Ablynx under a 2011 collaboration between both parties. 

Novel Nanobody for Osteoarthritis Enters Clinical Development

Saneca has been granted approval to manufacture and supply multiple dosage forms to Russia.  